Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Kompoti, Maria ^b   Mariolis, Anargiros ^a   Alevizos, Alevizos ^a,b,c   Kyrazis, Ioannis ^b   Protopsaltis, Ioannis ^b   Dimou, Eleni ^b   Lentzas, Ioannis ^a,b   Levisianou, Dimitrios ^b   Gova, Afroditi ^b   Melidonis, Andreas ^b  

^a Health Centre of Vyronas   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT DEPARTMENT; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

EID: 33750383702     PISSN: 14752840     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-5-21     Document Type: Article

References (15)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, taskinen MR, Groop L: Cardiovascular mortality and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
2. Haffner SM: The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97(2A):3A-11A.
3. Lorenzo C, Williams K, Hunt KJ, Haffner SM: Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care 2006, 29(3):625-30.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 288:2486-2497.
5. Alberti G: Introduction to the metabolic syndrome. Eur Heart J 2005, 7(Suppl D):3-5.
6. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214.
7. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
8. Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
9. Sackett DL, Hayes RB, Guyatt GH, Tugwell P: The interpretation of diagnostic data (Ch. 4). In Clinical Epidemiology: A Basic Science for Clinical Medicine 2nd edition. Little, Brown and Company, Boston MA; 1991:69-152.
10. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial (MRFIT). Diabetes Care 1993, 16:434-444.
11. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org; 1999.
12. Ford ES, Giles WH: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003, 52:2740-2747.
13. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring studies. Diabetes 2003, 52:2160-2167.
14. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P: Casale Monferrato Study. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004, 27:2689-2694.
15. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini P, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004, 21:52-58.